Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape

Iguratimod (IGU) is a novel synthetic small molecule disease modified anti-rheumatic drug approved only in Japan and China up to date. IGU plays an important immunomodulatory role in the synovial tissue of rheumatoid arthritis by inhibiting the production of immunoglobulins and cytokines and regulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Sisi Xie (Author), Shu Li (Author), Jing Tian (Author), Fen Li (Author)
Format: Book
Published: Frontiers Media S.A., 2020-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available